These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 20689291)

  • 41. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
    Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
    J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
    Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
    Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preoperative chemoradiation therapy for low rectal cancer. Impact on downstaging and sphincter-saving operations.
    Habr-Gama A; Perez RO; Kiss DR; Rawet V; Scanavini A; Santinho PM; Nadalin W
    Hepatogastroenterology; 2004; 51(60):1703-7. PubMed ID: 15532809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiation dose associated with local control in advanced anal cancer: retrospective analysis of 129 patients.
    Widder J; Kastenberger R; Fercher E; Schmid R; Langendijk JA; Dobrowsky W; Pötter R
    Radiother Oncol; 2008 Jun; 87(3):367-75. PubMed ID: 18501453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary malignant melanoma with surrounding melanosis in the anorectum.
    Kim J; Keum B; Seo YS; Kim YS; Jeen YT; Chun HJ; Um SH; Kim CD; Ryu HS
    Endoscopy; 2010; 42 Suppl 2():E47. PubMed ID: 20157885
    [No Abstract]   [Full Text] [Related]  

  • 46. [Cancers of the anus: 32 cases].
    Dem A; Kasse AA; Diop M; Toure P
    Dakar Med; 2000; 45(1):74-6. PubMed ID: 14666796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The role of radical surgery in the treatment of epidermoid carcinoma of the anal canal].
    Luna-Pérez P; Fernández A; Labastida S; Acevedo C; Torres S; Padilla R; Herrera Ornelas L
    Gac Med Mex; 1994; 130(5):380-5. PubMed ID: 7607369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV and anal cancer outcomes: a single institution's experience.
    Hogg ME; Popowich DA; Wang EC; Kiel KD; Stryker SJ; Halverson AL
    Dis Colon Rectum; 2009 May; 52(5):891-7. PubMed ID: 19502853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy.
    Dietl B; Marienhagen J; Schäfer C; Kölbl O
    Clin Oncol (R Coll Radiol); 2007 May; 19(4):228-33. PubMed ID: 17433968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Squamous-cell carcinoma of the rectum: a rare but curable tumor.
    Nahas CS; Shia J; Joseph R; Schrag D; Minsky BD; Weiser MR; Guillem JG; Paty PB; Klimstra DS; Tang LH; Wong WD; Temple LK
    Dis Colon Rectum; 2007 Sep; 50(9):1393-400. PubMed ID: 17661147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carcinoma of the anal canal: small steps in treatment advances.
    Eng C
    Clin Adv Hematol Oncol; 2011 Sep; 9(9):662-9. PubMed ID: 22402509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
    Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
    Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors associated with requiring a stoma for the management of anal cancer.
    Nguyen WD; Mitchell KM; Beck DE
    Dis Colon Rectum; 2004 Jun; 47(6):843-6. PubMed ID: 15054683
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
    Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of anal cancer in the HIV-positive population.
    Kauh J; Koshy M; Gunthel C; Joyner MM; Landry J; Thomas CR
    Oncology (Williston Park); 2005 Nov; 19(12):1634-8; discussion 1638-40, 1645 passim. PubMed ID: 16396154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term results of 28 esthesioneuroblastomas managed over 35 years.
    de Gabory L; Abdulkhaleq HM; Darrouzet V; Bébéar JP; Stoll D
    Head Neck; 2011 Jan; 33(1):82-6. PubMed ID: 20848423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Case report of long term survivor of metastatic cloacogenic carcinoma of the anal canal with chemotherapy.
    Fayaz S; Vasishta S; Motawy M
    Gulf J Oncolog; 2007 Jul; (2):65-8. PubMed ID: 20084726
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HIV positivity and anal cancer outcomes: A single-center experience.
    Wieghard N; Hart KD; Kelley K; Lu KC; Herzig DO; Mitin T; Thomas CR; Tsikitis VL
    Am J Surg; 2016 May; 211(5):886-93. PubMed ID: 26988618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemoradiotherapy for anal squamous cell carcinoma.
    Houlihan OA; O'Neill BD
    Surgeon; 2016 Aug; 14(4):202-12. PubMed ID: 27118047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Locally Recurrent Disease Related to Anal Canal Cancers.
    Sammour T; Rodriguez-Bigas MA; Skibber JM
    Surg Oncol Clin N Am; 2017 Jan; 26(1):115-125. PubMed ID: 27889030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.